The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...

Recognising that challenge, AstraZeneca's rare disease unit Alexion has launched an interactive storybook that can help ...

Martin, who was appointed as Inspector General for the USAID towards the end of 2023 by former President Joe Biden, was dismissed via an email from Trent Morse, deputy director of the White House ...

Super Bowl ads aren’t just entertainment; they’re cultural barometers. They reflect what resonates with audiences, what ...

Roche's sale of InterMune and Esbriet in the US comes as Boehringer revealed its own follow-up play in the IPF, category, ...

Novartis has agreed to buy Anthos Therapeutics from private equity firm Blackstone for $3.1 billion, adding a drug in ...

This can help individuals feel fuller for longer and can promote weight loss. When measured by traditional weight loss ...

Merck said in a brief statement that discussions are "advanced" but noted that "critical conditions have yet to be met" ...

The two positive studies mean that Boehringer can now seek approval for nerandomilast with a broad label claim in pulmonary ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...